NCT04459468 2026-01-08
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
University of Texas Southwestern Medical Center
Completed
Clinical Trials
6 trialsNCT05291338 2023-07-28
Pharmacogenetic Study in Hepatocellular Carcinoma Patients.
Damanhour University
Completed
NCT01877187 2020-04-15
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Yale University
Phase 2 Completed
NCT01229839 2019-03-06
Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC
Sun Yat-sen University
Phase 3 Completed
NCT00820053 2016-04-01
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
Eastern Hepatobiliary Surgery Hospital
Phase 2 Completed
NCT00870558 2011-08-16
Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed